A randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T-Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)
- Sponsor:
- ECOG-ACRIN Cancer Research Group
- Sponsor Study ID:
- EA4232
- CTO #:
- 104289
- NCT Number:
- NCT06724237
- Phase:
- III
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Non-Hodgkin's Lymphoma
- Study Objectives:
- To demonstrate improvement in progression free survival (PFS) in the autologous stem cell transplant (ASCT) arm compared to the observation arm.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Gurumurthi, Ash, at gurumurt@musc.edu .
- Study Coordinator, Mendiola, Hannah, at mendiola@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina